Full Text View
Tabular View
No Study Results Posted
Related Studies
The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome
This study has been completed.
Study NCT00215800   Information provided by Hemispherx Biopharma
First Received: September 16, 2005   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Fatigue Syndrome
Myalgic Encephalomyelitis
Additional conditions recognized in this trial
Encephalomyelitis
Fatigue
Fatigue Syndrome, Chronic
Syndrome
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Central Nervous System Infections
Disease
Encephalitis
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neuromuscular Diseases
Pathologic Processes
Signs and Symptoms
Virus Diseases
Interventions listed in this trial
Ampligen
More general drug interventions related to this trial
Anti-Infective Agents
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Hemispherx Biopharma


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services